ORPHAZYME A/S - ADR (ORPH)

ADR

0.87  -0.02 (-2.25%)

After market: 0.8002 -0.07 (-8.02%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2021-6-30)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
2017
(2017-12-31)
Revenue
13.15M0.000.000.000.00
Operating Expenses
841.83M608.53M335.95M231.65M131.04M
Research and Development
458.99M357.24M282.31M195.23M98.43M
Selling, General, and Administrative Expenses
382.84M246.09M49.84M35.05M31.99M
Operating Income
-828.68M-608.53M-335.95M-231.65M-131.04M
Interest Income/Expense
-19.19M-23.60M-7.04M-3.45M-621.00K
Other Income/Expense
N/A-3.03MN/AN/A-41.00K
Income Before Taxes
-847.86M-635.16M-343.00M-235.10M-131.70M
Income Tax
-2.25M-1.92M-5.50M-5.50M-5.50M
Net Income
-845.61M-633.25M-337.50M-229.60M-126.20M
EBITDA
-808.91M-603.33M-332.15M-230.29M-130.41M
 
Per Share Data
EPS Diluted Total Ops
-25.49-22.32-16.87-11.50-10.43
 
Statistics
Profit Margin
-6429.52%N/AN/AN/AN/A
Operating Profit Margin
-6300.77%N/AN/AN/AN/A

All data in DKK

Charts